Artrite reumatóide: Diagnóstico e Tratamento

Revista Brasileira de Reumatologia

Volumn 44, Issue 6, 2004, Pages 435-442

  Laurindo, I M M ^a   Ximenes, A C ^a   Lima, F A C ^a   Pinheiro, G R C ^a   Batistella, L R ^a   Bertolo, M B ^a   Alencar, P ^a   Xavier, R M ^a   Giorgi, R D N ^a   Ciconelli, R M ^a   Radominski, S C ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84862142971     PISSN: 04825004     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0482-50042004000600007     Document Type: Article

References (29)

1. Lipski PE. Rheumatoid arthitis. In: Harrison's Principles of Internal Medicine. New York: McGraw Hill; 1998.
2. American College of Rheumatology Subcommitte on Rheumatoid Arthritis Guidelines. Guidelines for the management of rheumatoid arthritis. Arthritis Rheum 46:328-46, 2002.
3. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for classification of rheumatoid arthritis. Arthritis Rheum 31:315-24, 1988.
4. Albers JM, Paimela L, Kurki P, et al. Treatment strategy, disease activity, and outcome in four cohorts of patients with early rheumatoid arthritis. Ann Rheum Dis 60:453-8, 2001.
5. Gotzsche PC, Johansen HK. Short-term low-dose corticosteroids vs placebo and nonsteroidal antiinflammatory drugs in rheumatoid arthritis. Cochrane Database Syst Rev 2:CD000189, 2000.
6. Moreland LW, O'Dell JR. Glucocorticoids and rheumatoid arthritis: Back to the future? Arthritis Rheum 46:2553-63, 2002.
7. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. Arthritis Rheum 44:1496-503, 2001.
8. Suarez-Almazor ME, Belseck E, Shea B, HomikJ, Wells G, Tugwell P. Antimalarials for treating rheumatoid arthritis. Cochrane Database Syst Rev 4:CD000959, 2000.
9. van den Borne BE, Landewe RB, Rietveld JH, et al. Chloroquine therapy in patients with recent-onset rheumatoid arthritis: the clinical response can be predicted by the low level of acute-phase reaction at baseline. Clin Rheumatol 18:369-72, 1999.
10. Suarez-Almazor ME, Belseck E, Shea B, Wells G, Tugwell P. Sulfasalazine for rheumatoid arthritis. Cochrane Database Syst Rev 2:CD000958, 2000.
11. Sharp JT, Strand V, Leung H, Hurley F, Loew-Friedrich I. Treatment with leflunomide slows radiographic progression of rheumatoid arthritis: results from three randomized controlled trials or leflunomidc in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group. Arthritis Rheum 43:495-505, 2000.
12. Suarez-Almazor ME, Belseck E, Shea B, Wells G, Tugwell P. Methotrexate for rheumatoid arthritis. Cochrane Database Syst Rev 2:CD000957, 2000.
13. Cohen S. Cannon GW, SchiffM, et al. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate: utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator group. Arthritis Rheum 44:1984-92, 2001.
14. Suarez-Almazor ME, Spooner C, Belseck E. Azathioprine for treating rheumatoid arthritis. Cochrane Database Syst Rev 4:CD001461, 2000.
15. Wells G, Haguenauer D, Shea B, Suarez-Almazor ME, Welch VA, Tugwell R. Cyclosporine for rheumatoid arthritis. Cochrane Database Syst Rev 2: CD001083, 2000.
16. Stein CM, Pincus T, Yocura D, et al. Combination treatment of severe rheumatoid arthritis with cyclosporine and methotrexate for forty-eight weeks: an open-label extension study. The Methotrexate- Cyclosporine Combination Study Group. Arthritis Rheum 40: 1843-51, 1997.
17. O'Dell JR, LeffR, Paulsen G, Haire C, Mallek J, EckhoffPJ, et al. Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: results of a two-year, randomized, double 24. blind, placebo-controlled trial. Arthritis Rheum 46:1164-70, 2002.
18. Weinblatt ME, Kremer JM, Coblyn JS, et al. Pharmacokinetics, safety, and efficacy of combination treatment with methotrexate and leflunomide in patients with active rheumatoid arthritis. Arthritis 25. Rheum 42:1322-8, 1999.
19. Criscione LG, St. Clair EW. Tumor necrosis factor-alfa antagonists for the treatment of rheumatic diseases. Curr Opin Rheumatol 14:204-11, 2002.
20. Funt DE, Breedveld FC, Burmester GR, et al. Update consensus statement on tumor necrosis factor blocking agents for the treatment of rheumatoid arthritis (May 2000). Ann Rheum Dis 59(suppl.l):il-2,2000.
21. Maini RN, Breedveld FC, Kaldcn JR, et al. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha 27. monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. Arthritis Rheum 41:1552-63, 1998.
22. Lipsky PE, van der Heijde DM, St Clair EW, et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. N Engl J Med 343:1594-602, 2000.
23. Moreland LW, SchiffMH, Baumgartner SW, et al. Etanercept 29. therapy in rheumatoid arthritis: a randomized, controlled trial. Ann Intern Med 130:478-86, 1999.
24. Weinblatt ME, Kremer JM, Bankhurst AD, et al. A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med 340:253-9, 1999.
25. Weinblatt ME, Keystone EC, Furst DE, et al. Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial. Arthritis Rheum 48:35-45, 2003
26. Furst DE, SchiffMH, Fleischmann RM, et al. Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis). J Rhcumatol 30:2563-71, 2003
27. Mangini C, Melo FAF. Artrite rcumatoide, terapia imunossupressora e tuberculose. Rev Bras Reumatol 2003; 43:X1 (editorial).
28. HochbergMC, TracyJK, Hawkins-Holt M, FloresRH. Comparison of the efficacy of the tumour necrosis factor alpha blocking agents adalimumab, etanercept, and infliximab when added to methotrexate in patients with active rheumatoid arthritis. Ann Rheum Dis 62(suppl 2):iil3-6, 2003.
29. Felson D, La Valley MP, Baldassare AR, et al. The Prosorba column for treatment of refractory rheumatoid arthritis: a randomized, double blind, sham-controlled trial. Arthritis Rheum 42:2153-9, 1999.